Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies

Hannah M Knochelmann1,2,3, Amalia M Rivera-Reyes2,3, Megan M Wyatt2,3

  • 1Department of Microbiology & Immunology, Medical University of South Carolina, Charleston, South Carolina, USA.

Oncoimmunology
|August 19, 2021
PubMed
Summary

Tumor-infiltrating lymphocytes (TIL) show promise in treating metastatic cancers but often lead to relapse. This study explores murine TIL characteristics, finding similarities to human TIL, which could improve cancer immunotherapy strategies.

Related Concept Videos